Glucokinase mutations, insulin secretion, and diabetes mellitus.

The glycolytic enzyme glucokinase plays a key role in glucose sensing by the insulin-secreting pancreatic beta-cells, and mutations in the gene encoding this enzyme are a common cause of maturity-onset diabetes of the young (MODY), a form of non-insulin-dependent diabetes mellitus characterized by autosomal-dominant inheritance and onset before 25 years of age. Twenty-eight different mutations in this gene have been identified in subjects with MODY. Clinical studies have shown that subjects with MODY due to mutations in glucokinase have elevated fasting and postprandial glucose levels with normal first-phase insulin secretory responses to intravenous glucose injection and normal insulin secretion rates over a 24-h period. However, the dose-response curve relating glucose and insulin secretion rate obtained during graded intravenous glucose infusions was shifted to the right in subjects with glucokinase mutations, indicating decreased sensitivity to glucose. In normal subjects, the beta-cell was most sensitive to an increase in glucose concentration between 5.5 and 6.0 mM, whereas in patients with glucokinase mutations, the maximum responsiveness was increased to 6.5 to 7.5 mM glucose. These studies indicate that glucokinase is an important component of the glucose-sensing mechanism of the beta-cell.

[1]  J. Halter,et al.  Altered Insulin Secretory Responses to Glucose in Subjects with a Mutation in the MODY1 Gene on Chromosome 20 , 1995, Diabetes.

[2]  J. Beckmann,et al.  A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q , 1995, Nature Genetics.

[3]  W. Malaisse,et al.  Insulin secretion and beta cell metabolism , 1995 .

[4]  H. Luthman,et al.  Glucose Potentiation of Arginine-Induced Insulin Secretion is Impaired in Subjects With a Glucokinase Glu256Lys Mutation , 1994, Diabetes.

[5]  I. Weber,et al.  Glucokinase: structural analysis of a protein involved in susceptibility to diabetes. , 1994, The Journal of biological chemistry.

[6]  J. H. Johnson,et al.  Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels. , 1994, The Journal of biological chemistry.

[7]  I. Weber,et al.  Molecular Model of Human β-Cell Glucokinase Built by Analogy to the Crystal Structure of Yeast Hexokinase B , 1994, Diabetes.

[8]  P. Froguel,et al.  Six Mutations in the Glucokinase Gene Identified in MODY by Using a Nonradioactive Sensitive Screening Technique , 1994, Diabetes.

[9]  E. Mosekilde,et al.  Compensation in Pancreatic β-Cell Function in Subjects With Glucokinase Mutations , 1994, Diabetes.

[10]  E. Van Schaftingen,et al.  Short‐term control of glucokinase activity: role of a regulatory protein , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  G. Weir,et al.  Ribozyme-mediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Clément,et al.  Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. , 1994, The Journal of clinical investigation.

[13]  G. Bell,et al.  Mutations in the Glucokinase Gene are not a Major Cause of Late‐onset Type 2 (Non‐insulin‐dependent) Diabetes Mellitus in Japanese subjects , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[14]  M. Magnuson,et al.  Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. , 1994, The Journal of biological chemistry.

[15]  H. Yki-Järvinen.  Pathogenesis of non-insulin-dependent diabetes mellitus , 1994, The Lancet.

[16]  J. Halter,et al.  Abnormal Insulin Secretion, Not Insulin Resistance, Is the Genetic or Primary Defect of MODY in the RW Pedigree , 1994, Diabetes.

[17]  J. Beckmann,et al.  Linkage Analysis and Molecular Scanning of Glucokinase Gene in NIDDM Families , 1993, Diabetes.

[18]  Y. Yazaki,et al.  Sequence Variations of the Glucokinase Gene in Japanese Subjects With NIDDM , 1993, Diabetes.

[19]  C. L. Blackburn,et al.  Identification of Glucokinase Mutations in Subjects With Gestational Diabetes Mellitus , 1993, Diabetes.

[20]  Y. Shinohara,et al.  Evolution of the type II hexokinase gene by duplication and fusion of the glucokinase gene with conservation of its organization. , 1993, The Journal of biological chemistry.

[21]  M. Stoffel,et al.  Mutations of the human glucokinase gene and diabetes mellitus , 1993, Trends in Endocrinology & Metabolism.

[22]  A. Hattersley,et al.  Linkage Analysis of Glucokinase Gene With NIDDM in Caucasian Pedigrees , 1992, Diabetes.

[23]  R. C. Turner,et al.  Missense glucokinase mutation in maturity–onset diabetes of the young and mutation screening in late–onset diabetes , 1992, Nature Genetics.

[24]  M. Permutt,et al.  Human glucokinase gene: isolation, structural characterization, and identification of a microsatellite repeat polymorphism. , 1992, Molecular endocrinology.

[25]  M. Permutt,et al.  Human Islet Glucokinase Gene: Isolation and Sequence Analysis of Full-Length cDNA , 1992, Diabetes.

[26]  J. Beckmann,et al.  Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[27]  D. Granner,et al.  Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. , 1992, Annual review of physiology.

[28]  J. Wilson,et al.  Complete amino acid sequence of the type II isozyme of rat hexokinase, deduced from the cloned cDNA: comparison with a hexokinase from novikoff ascites tumor. , 1991, Archives of biochemistry and biophysics.

[29]  D. A. Schwab,et al.  Complete amino acid sequence of the type III isozyme of rat hexokinase, deduced from the cloned cDNA. , 1991, Archives of biochemistry and biophysics.

[30]  N J Cox,et al.  Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  F M Matschinsky,et al.  Glucokinase as Glucose Sensor and Metabolic Signal Generator in Pancreatic β-Cells and Hepatocytes , 1990, Diabetes.

[32]  R. Printz,et al.  The amino acid sequence of rat liver glucokinase deduced from cloned cDNA. , 1989, The Journal of biological chemistry.

[33]  F. Matschinsky,et al.  New perspectives on pancreatic islet glucokinase. , 1984, The American journal of physiology.

[34]  F. Raushel,et al.  Substrate synergism and the kinetic mechanism of yeast hexokinase. , 1982, Biochemistry.

[35]  R. Schimke,et al.  STUDIES ON ISOZYMES OF HEXOKINASE IN ANIMAL TISSUES * , 1968, Annals of the New York Academy of Sciences.